Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience-Reference-Cited by-同舟云学术

Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience

Published:2014-02-19 Issue:10 Volume:85 Page:1116-1121
ISSN:0022-3050
Container-title:Journal of Neurology, Neurosurgery & Psychiatry
language:en
Short-container-title:J Neurol Neurosurg Psychiatry

Author:

Burman Joachim,Iacobaeus Ellen,Svenningsson Anders,Lycke Jan,Gunnarsson Martin,Nilsson Petra,Vrethem Magnus,Fredrikson Sten,Martin Claes,Sandstedt Anna,Uggla Bertil,Lenhoff Stig,Johansson Jan-Erik,Isaksson Cecilia,Hägglund Hans,Carlson Kristina,Fagius Jan

Publisher

BMJ

Subject

Psychiatry and Mental health,Neurology (clinical),Surgery

Reference18 articles.

1. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study;Fassas;Bone Marrow Transplant,1997

2. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores;Burt;Blood,2003

3. Early highly aggressive MS successfully treated by hematopoietic stem cell transplantation;Fagius;Mult Scler,2008

4. Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study;Burt;Lancet Neurol,2009

5. High-dose immunoablation with autologous haematopoietic stem cell transplantation in aggressive multiple sclerosis: a single centre 10-year experience;Krasulova;Mult Scler,2010

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Healthcare utilization and costs associated with autologous haematopoietic stem cell transplantation in Norwegian patients with relapsing remitting multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-04

2. Effectiveness of autologous haematopoietic stem cell transplantation versus natalizumab in progressive multiple sclerosis;Journal of Neurology, Neurosurgery & Psychiatry;2024-03-27

3. Evoked potentials after autologous hematopoietic stem cell transplantation for multiple sclerosis;Multiple Sclerosis and Related Disorders;2024-03

4. Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial;BMJ Open;2024-02

5. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis;Neurologic Clinics;2024-02